Skip to main content

Month: January 2025

FIFA+ Selects Magnite as Part of Their Global Programmatic Expansion to Power Video Advertising on FIFA+ and FAST Channels Globally

Collaboration comes as FIFA+ continues to revolutionize and democratize the football streaming experience for fans across the globe LONDON, Jan. 14, 2025 (GLOBE NEWSWIRE) — Magnite (NASDAQ: MGNI), the world’s largest independent sell-side advertising company, today announced its selection as FIFA+’s global programmatic provider. Magnite will power video and display advertising on FIFA+ across North America, EMEA, LATAM, and APAC. The collaboration marks another important step in FIFA+’s efforts to revolutionize the football streaming experience for fans worldwide, bringing previously non-televised games to audiences for free. FIFA+ will leverage Magnite’s industry-leading product suite including Magnite Streaming, SpringServe and Magnite DV+, to monetize their content on a global scale and bring a superior viewing experience...

Continue reading

Organizations are increasingly aware of the environmental footprint of Gen AI, but most aren’t able to address it alone

Press contact:Victoire GruxTel.: +33 6 04 52 16 55E-mail: victoire.grux@capgemini.com Organizations are increasingly aware of the environmental footprint of Gen AI, but most aren’t able to address it aloneAlmost half of executives believe that their use of Gen AI has driven a rise in Greenhouse Gas (GHG) emissions, and 42% have had to relook at their climate goals However, more than half say driving efficiency is more important than measuring impact.Paris, January 14, 2024 – The Capgemini Research Institute’s report into the sustainability of generative AI, ‘Developing sustainable Gen AI’, published today, shows that Gen AI has a significant and growing negative environmental impact. However, many organizations are failing to appropriately track this growing footprint, which is jeopardizing their ESG objectives. As businesses weigh...

Continue reading

Quadient Secures New c.$1.6 Million Contract to Enhance U.S. Government Agency’s Mail Automation Capacity

Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announced today that it has been selected by a U.S. government agency to modernize its mail automation infrastructure in a contract valued at c.$1.6 million. This follows a previous announcement in October 2024, where Quadient was awarded a contract worth nearly $1 million for a similar modernization project with another federal agency. The agency processes over 35 million notices annually, including critical documents related to a range of public services. Faced with outdated equipment and growing mail volumes, the agency needed a solution that would improve operational efficiency and ensure timely delivery of essential paperwork. Under the new contract, Quadient will be providing 11 new high-performance systems, including...

Continue reading

NBPE Announces 1H 2025 Dividend

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS St Peter Port, Guernsey     14 January 2025 NB Private Equity Partners (the “Company” or “NBPE”), the $1.3bn, FTSE 250, listed private equity investment company managed by Neuberger Berman, today announces its 1H 2025 Dividend. 1H 2025 Dividend1H 2025 dividend payment of $0.47 per share to be paid on 28 February 2025 Annualised dividend yield on 30 November 2024 NAV of 3.4% and 5.0% on closing share price of £15.50 on 13 January 2025 The 1H 2025 dividend is the 25th consecutive dividend paid, resulting in over $380 million declared or returned to shareholders by way of dividends, since 2013Dividend InformationWhile NBPE declares dividends...

Continue reading

Mobilize and Autostrade per l’Italia forge a strategic alliance to power sustainable mobility in Italy

PRESS RELEASEParis, France – 14 January 2025 MOBILIZE AND AUTOSTRADE PER L’ITALIA FORGE A STRATEGIC ALLIANCE TO POWER SUSTAINABLE MOBILITY IN ITALY Renault Group through its Mobilize brand and Autostrade per l’Italia through its subsidiary Free To X have signed a framework agreement to develop fast-charging infrastructure in Italy. As part of the transaction, Mobilize will acquire a significant stake in Free To X, a subsidiary of Autostrade per l’Italia, dedicated to fast charging. The existing Free To X network comprises over a hundred High-Power charging stations primarily located on highways, with an average distance of approximately 50 km between each station. The parties intend to enhance Italy’s charging infrastructure, focusing on premium locations beyond highways.In a landmark move for the electric mobility sector, Mobilize,...

Continue reading

EVK Joins Headwall Group to Strengthen Market Leadership in Hyperspectral Imaging and Industrial Sensor Solutions

EVK DI KerschhagglEVK DI Kerschhaggl, now a Headwall Group company, is a world leader in developing and manufacturing sensor-based sorting and analysis systems for the recycling, mining, food, pharmaceutical, and chemical industries.Headwall Group Welcomes EVK, Diversifying Offerings and Deepening Capabilities with Additional Innovative TechnologiesMark Willingham, CEO of Headwall (left), and Matjaz Novak, CEO of EVK (right), shake hands as EVK is brought into the Headwall Group of companies, significantly enhancing the group’s portfolio and bolstering its presence in the industrial machine vision market.Bolton, Massachusetts and Raaba, Austria, Jan. 14, 2025 (GLOBE NEWSWIRE) — Headwall Group (“Headwall”), a global leader in high-performance spectral imaging solutions and optical components and a portfolio...

Continue reading

HUTCHMED Announces NMPA Full Approval for ORPATHYS® (savolitinib) in China for Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC

— Indication expands to include treatment-naïve patients — — The 2021 conditional approval in previously treated patients converted to full approval — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 14, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that the supplemental New Drug Application for ORPATHYS® (savolitinib) has been granted approval by the China National Medical Products Administration (“NMPA”) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (“NSCLC”) with MET exon 14 skipping alteration. The NMPA has also converted the prior conditional approval of ORPATHYS® in the previously treated patient population to full approval. The new label indication for ORPATHYS® will now include both treatment-naïve and previously...

Continue reading

Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial

Independent Data Safety Monitoring Board (DSMB) recommends study to proceed without modifications based on initial safety assessment of 400 participant 30-day data The company plans to progress the trial to enrollment of 10,000 participants, upon favorable review from the U.S. Food and Drug Administration (FDA) and upon Biomedical Advanced Research and Development Authority (BARDA) approval SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today announced that an independent DSMB, which conducted a planned review of the 30-day safety data from a sentinel cohort of 400 participants in its COVID-19 Phase 2b trial, has recommended that the study continue without any modifications. “We are pleased with the DSMB recommendation, an important step forward in conducting our head-to-head study versus...

Continue reading

Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025

2024 preliminary unaudited revenue in the range of approximately $1.355 billion – $1.357 billion, up approximately 7.7% – 7.9% year-over-year 2024 preliminary constant currency revenue* increased in the range of approximately 8.4% – 8.6% year over year 2024 financial results and 2025 guidance to be released February 25, 2025* Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial measure is included under the heading “Non-GAAP Financial Measure” below. SOUTH JORDAN, Utah, Jan. 13, 2025 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced preliminary unaudited revenue in the range of approximately $1.355 to $1.357 billion...

Continue reading

B2Gold Announces Amended Shareholder Return Strategy, including New Dividend Framework and Intention to Implement a Normal Course Issuer Bid

VANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) announces amendments to its shareholder returns strategy to increase financial flexibility as it completes its current phase of organic growth, including the anticipated commencement of initial production from Fekola Regional in Mali, the completion of construction of the Goose Mine in Nunavut, Canada, the development of the Antelope deposit at the Otjikoto Mine in Namibia, and de-risking activities at the Gramalote Project in Colombia. All dollar figures are in United States dollars unless otherwise indicated. New Dividend Framework Management and the Board of Directors (the “Board”) of B2Gold have completed a comprehensive review of its existing dividend level and approved a change in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.